2019 WMS临床实践指南:糖尿病的管理

2019-11-18 荒野医学协会 Wilderness Environ Med. 2019 Nov 18.

2019年11月,荒野医学协会(WMS)发布了糖尿病管理指南,WMS成立专家小组针对1型糖尿病和2型糖尿病的治疗制定循证指导,主要内容涉及野外糖尿病的识别,预防以及并发症的管理。

中文标题:

2019 WMS临床实践指南:糖尿病的管理

英文标题:

Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management.

发布机构:

荒野医学协会

发布日期:

2019-11-18

简要介绍:

2019年11月,荒野医学协会(WMS)发布了糖尿病管理指南,WMS成立专家小组针对1型糖尿病和2型糖尿病的治疗制定循证指导,主要内容涉及野外糖尿病的识别,预防以及并发症的管理。

 

拓展指南:糖尿病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 WMS临床实践指南:糖尿病的管理)] GetToolGuiderByIdResponse(projectId=1, id=663841c00183a81d, title=2019 WMS临床实践指南:糖尿病的管理, enTitle=Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management., guiderFrom=Wilderness Environ Med. 2019 Nov 18., authorId=null, author=, summary=2019年11月,荒野医学协会(WMS)发布了糖尿病管理指南,WMS成立专家小组针对1型糖尿病和2型糖尿病的治疗制定循证指导,主要内容涉及野外糖尿病的识别,预防以及并发症的管理。 , cover=, journalId=null, articlesId=null, associationId=1000, associationName=荒野医学协会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 18 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年11月,荒野医学协会(WMS)发布了糖尿病管理指南,WMS成立专家小组针对1型糖尿病和2型糖尿病的治疗制定循证指导,主要内容涉及野外糖尿病的识别,预防以及并发症的管理。 </P> <P> </P>拓展指南:<strong>与<font color=red>糖尿病</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=ae0501c00183a41b" title="《2019年欧洲心脏病学会和欧洲糖尿病研究学会糖尿病管理指南》解读" target=_blank>《2019年欧洲心脏病学会和欧洲糖尿病研究学会糖尿病管理指南》解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=32ff91c001828880" title="2019 临床建议:糖尿病护理中动态血糖曲线的应用" target=_blank>2019 临床建议:糖尿病护理中动态血糖曲线的应用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=193281c001818193" title="治疗糖尿病药物及生物制品临床试验指导原则" target=_blank>治疗糖尿病药物及生物制品临床试验指导原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=83c981c0018180c2" title="治疗2型糖尿病新药的心血管风险评价指导原则" target=_blank>治疗2型糖尿病新药的心血管风险评价指导原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6c0791c00180a3a5" title="2019《国际糖尿病足疾病预防和管理指南》解读" target=_blank>2019《国际糖尿病足疾病预防和管理指南》解读</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6543, appHits=742, showAppHits=31, pcHits=4164, showPcHits=2288, likes=102, shares=6, comments=4, approvalStatus=1, publishedTime=Sat Nov 30 13:17:21 CST 2019, publishedTimeString=2019-11-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 30 13:17:21 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:29:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 WMS临床实践指南:糖尿病的管理)])
2019 WMS临床实践指南:糖尿病的管理
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=924242, encodeId=d7eb924242c8, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:58:47 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916844, encodeId=5556916844df, content=学以致用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08701331575, createdName=hailinren, createdTime=Fri Jan 15 11:13:36 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898585, encodeId=170689858505, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Wed Nov 11 23:16:51 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2021-02-12 ms7000001623538615

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=924242, encodeId=d7eb924242c8, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:58:47 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916844, encodeId=5556916844df, content=学以致用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08701331575, createdName=hailinren, createdTime=Fri Jan 15 11:13:36 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898585, encodeId=170689858505, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Wed Nov 11 23:16:51 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2021-01-15 hailinren

    学以致用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=924242, encodeId=d7eb924242c8, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:58:47 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916844, encodeId=5556916844df, content=学以致用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08701331575, createdName=hailinren, createdTime=Fri Jan 15 11:13:36 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898585, encodeId=170689858505, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Wed Nov 11 23:16:51 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-11 ms4000000062793346

    好好学习

    0